Related references
Note: Only part of the references are listed.BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy
Jonathan Fletcher et al.
GUT (2011)
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies
H. El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Gastroesophageal Reflux Disease and Obesity
Girish Anand et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
John Dent et al.
GUT (2010)
Overlapping gastroesophageal reflux disease and irritable bowel syndrome: Increased dysfunctional symptoms
Shadi Sadeghi Yarandi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis - results from the EXPO study
J. Labenz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease
G. Holtmann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study
M. Nocon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors
A. S. Raghunath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Proton Pump Inhibitor Failure-What Are the Therapeutic Options?
Ronnie Fass
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
A Systematic Review of the Definitions, Prevalence, and Response to Treatment of Nocturnal Gastroesophageal Reflux Disease
Lauren B. Gerson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Predictors of heartburn resolution and erosive esophagitis in patients with GERD
Roy C. Orlando et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Management of heartburn not responding to proton pump inhibitors
R. Fass et al.
GUT (2009)
Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms
Shahin Ayazi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Making trials matter: pragmatic and explanatory trials and the problem of applicability
Shaun Treweek et al.
TRIALS (2009)
Health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease
O. Chassany et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease
B. Nojkov et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal relux patients
N. Siupsinskiene et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2008)
Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population
H.-K. Jung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Erosive esophagitis and nonerosive reflux disease (NERD) - Comparison of epidemiologic, physiologic, and therapeutic characteristics
Ronnie Fass
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
Look -: but also listen!: ReQuest™:: An essay on a new validated scale to assess the outcome of GERD treatment
Karna D. Bardhan et al.
DIGESTION (2007)
The construction of a new evaluative GERD questionnaire -: Methods and state of the art
David Armstrong et al.
DIGESTION (2007)
Novel measurement of rapid treatment success with ReQuest (TM) : First and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20mg pantoprazole or 20 mg esomeprazole
Hubert Moennikes et al.
DIGESTION (2007)
Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse
Dirk Glatzel et al.
DIGESTION (2007)
Studying the overlap between IBS and GERD: A systematic review of the literature
Igor Nastaskin et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Predictors of treatment response in patients with non-erosive reflux disease
N. J. Talley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Body-mass index and symptoms of gastroesophageal reflux in women
Brian C. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The general practitioner's approach to irritable bowel syndrome: From intention to practice
M Bellini et al.
DIGESTIVE AND LIVER DISEASE (2005)
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease
F Pace et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next?
R Fass et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Overlap of gastrointestional symptom complexes in a US community
GR Locke et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Assessing symptoms in gastroesophageal reflux disease: How well do clinicians' assessments agree with those of their patients?
E McColl et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Systematic review:: do we need a new gastro-oesophageal reflux disease questionnaire?
V Stanghellini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Systematic review: Geographical and ethnic differences in gastro-oesophageal reflux disease
JY Kang
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease
R Shaker et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Review article: sleep and its relationship to gastro-oesophageal reflux
WC Orr et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease
KD Bardhan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Evaluation of GERD symptoms during therapy - Part II. Psychometric evaluation and validation of the new questionnaire ReQuest (TM) in erosive GERD
H Monnikes et al.
DIGESTION (2004)
Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis
RBH Williams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Evaluation of GERD symptoms during therapy - Part I. Development of the new GERD questionnaire ReQuest (TM)
KD Bardhan et al.
DIGESTION (2004)
Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: An evaluation based on clinical practice
V Garrigues et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux
M Pimentel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
T Kiljander et al.
RESPIRATORY MEDICINE (2001)
Share Paper
